检索结果 - Victor A. O. Martins

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    P20 HERPES VIRUSES ORAL SHEDDING IN CHRONIC RENAL PATIENTS

    P20 HERPES VIRUSES ORAL SHEDDING IN CHRONIC RENAL PATIENTS 由 Débora Pallos, Laura Masami Sumita, Caroline Perozini, Victor A. O. Martins, L. Pavesi, C.S. Pannuti, Gilson Fernandes Ruivo, Paulo Henrique Braz‐Silva

    出版 2016
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Frequency and Evolution of Acute Oral Complications in Patients Undergoing Radiochemotherapy Treatment for Head and Neck Squamous Cell Carcinoma

    Frequency and Evolution of Acute Oral Complications in Patients Undergoing Radiochemotherapy Treatment for Head and Neck Squamous Cell Carcinoma 由 Michelle Palmieri, Dmitry José de Santana Sarmento, André Pereira Falcão, Victor A. O. Martins, Thaís Bianca Brandão, Karina Morais-Faria, Ana Carolina Prado Ribeiro, Bengt Hasséus, Daniel Giglio, Paulo Henrique Braz‐Silva

    出版 2019
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Primary dental care treatment in primary Sjögren's syndrome: a possible role in improving salivary flow rate

    Primary dental care treatment in primary Sjögren's syndrome: a possible role in improving salivary flow rate 由 Victor A. O. Martins, Tamires F. Floriano, Elaine Pires Leon, Lorena Elizabeth Betancourt Villamarín, Giordano B. H. Deveza, Nádia Emi Aikawa, Clóvis A. Silva, Léonard de Vinci Kanda Kupa, Maria Paula S.M. Peres, Paulo Henrique Braz‐Silva, Eloísa Bonfá, Sandra Gofinet Pasoto

    出版 2022
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Anti-SARS-CoV-2 inactivated vaccine in patients with ANCA-associated vasculitis: Immunogenicity, safety, antibody decay and the booster dose

    Anti-SARS-CoV-2 inactivated vaccine in patients with ANCA-associated vasculitis: Immunogenicity, safety, antibody decay and the booster dose 由 Rosa Maria Rodrigues Pereira, Marilia Ambiel Dagostin, Valéria F. Caparbo, Lucas Peixoto Sales, Sandra Gofinet Pasoto, Clóvis A. Silva, Emily Figueiredo Neves Yuki, Carla Gonçalves Schahin Saad, Ana Cristina de Medeiros Ribeiro, Léonard de Vinci Kanda Kupa, Solange Fusco, Victor A O Martins, Carolina Campagnoli Machado Freire Martins, Carmen Sílvia Valente Barbas, Samuel Katsuyuki Shinjo, Nádia Emi Aikawa, Eloísa Bonfá

    出版 2022
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Immunogenicity and safety of an inactivated virus vaccine against SARS-CoV-2 in patients with autoimmune rheumatic diseases

    Immunogenicity and safety of an inactivated virus vaccine against SARS-CoV-2 in patients with autoimmune rheumatic diseases 由 Eloísa Bonfá, Ana Cristina de Medeiros Ribeiro, Nádia Emi Aikawa, Carla Gonçalves Schahin Saad, Emily Figueiredo Neves Yuki, Tatiana do Nascimento Pedrosa, Solange Fusco, Priscila Tagliaferro Rojo, Rosa Maria Rodrigues Pereira, Samuel Katsuyuki Shinjo, Danieli Andrade, Percival D. Sampaio‐Barros, Carolina Torres Ribeiro, Giordano B. H. Deveza, Victor A. O. Martins, Clóvis A. Silva, Marta Lopes, Alberto Duarte, Leila Antonângelo, Éster Cerdeira Sabino, Esper G. Kallás, Sandra Sandra G. Pasoto

    出版 2021
    获取全文
    Pré-impressão
    加到收藏夹
    Saved in:
  6. 6
    Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial

    Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial 由 Ana Cristina de Medeiros Ribeiro, Nádia Emi Aikawa, Carla Gonçalves Schahin Saad, Emily Figueiredo Neves Yuki, Tatiana do Nascimento Pedrosa, Solange Fusco, Priscila Tagliaferro Rojo, Rosa Maria Rodrigues Pereira, Samuel Katsuyuki Shinjo, Danieli Andrade, Percival D. Sampaio‐Barros, Carolina Torres Ribeiro, Giordano B. H. Deveza, Victor A. O. Martins, Clóvis A. Silva, Marta Heloísa Lopes, Alberto J. S. Duarte, Leila Antonângelo, Éster Cerdeira Sabino, Esper G. Kallás, Sandra Gofinet Pasoto, Eloísa Bonfá

    出版 2021
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: A phase 4 trial

    Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: A phase 4 trial 由 Ana Cristina de Medeiros Ribeiro, Nádia Emi Aikawa, Carla Gonçalves Schahin Saad, Emily Figueiredo Neves Yuki, Tatiana do Nascimento Pedrosa, Solange Fusco, Priscila T. Rojo, Rosa Maria Rodrigues Pereira, Samuel Katsuyuki Shinjo, Danieli Andrade, Percival D. Sampaio‐Barros, Carolina Torres Ribeiro, Giordano B. H. Deveza, Victor A. O. Martins, Clóvis A. Silva, Marta Heloísa Lopes, Alberto J. S. Duarte, Leila Antonângelo, Éster Cerdeira Sabino, Esper G. Kallás, Sandra Gofinet Pasoto, Eloísa Bonfá

    出版 2021
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Anti-SARS-CoV-2 immunogenicity decay and incident cases six months after Sinovac-CoronaVac inactivated vaccine in autoimmune rheumatic diseases patients: phase 4 prospective trial

    Anti-SARS-CoV-2 immunogenicity decay and incident cases six months after Sinovac-CoronaVac inactivated vaccine in autoimmune rheumatic diseases patients: phase 4 prospective trial 由 Eloísa Bonfá, Clóvis A. Silva, Ana Cristina de Medeiros Ribeiro, Léonard de Vinci Kanda Kupa, Emily Figueiredo Neves Yuki, Sandra Sandra G. Pasoto, Carla Gonçalves Schahin Saad, Solange Fusco, Rosa Maria Rodrigues Pereira, Samuel Katsuyuki Shinjo, Ari Stiel Radu Halpern, Eduardo Ferreira Borba, Fernando Henrique Carlos de Souza, Lissiane Guedes, Renata Miossi, Karina Rossi Bonfiglioli, Diogo Souza Domiciano, Andrea Yukie Shimabuco, Danieli Andrade, Luciana Parente Costa Seguro, Ricardo Fuller, Percival D. Sampaio‐Barros, Ana Paula Luppino Assad, Júlio César Bertacini de Moraes, Cláudia Goldenstein‐Schainberg, Henrique Ayres Mayrink Giardini, Henrique Silva, Victor A. O. Martins, Lorena Elizabeth Betancourt Villamarín, Renata Soares, Lucas Peixoto Sales, Carlo Scognamiglio Renner Araújo, Matheus Silva, Dilson M. N. Filho, Marta Heloísa Lopes, Alberto Duarte, Alberto Duarte, Esper G. Kallás, Esper G. Kallás, Nádia Emi Aikawa

    出版 2021
    获取全文
    Pré-impressão
    加到收藏夹
    Saved in:
  9. 9
    Immunogenicity decay and case incidence six months post Sinovac-CoronaVac vaccine in autoimmune rheumatic diseases patients

    Immunogenicity decay and case incidence six months post Sinovac-CoronaVac vaccine in autoimmune rheumatic diseases patients 由 Clóvis A. Silva, Ana Cristina de Medeiros Ribeiro, Léonard de Vinci Kanda Kupa, Emily Figueiredo Neves Yuki, Sandra Gofinet Pasoto, Carla Gonçalves Schahin Saad, Solange Fusco, Rosa Maria Rodrigues Pereira, Samuel Katsuyuki Shinjo, Ari Stiel Radu Halpern, Eduardo Ferreira Borba, Fernando Henrique Carlos de Souza, Lissiane Karine Noronha Guedes, Renata Miossi, Karina Rossi Bonfiglioli, Diogo Souza Domiciano, Andrea Yukie Shimabuco, Danieli Andrade, Luciana Parente Costa Seguro, Ricardo Fuller, Percival D. Sampaio‐Barros, Ana Paula Luppino Assad, Júlio César Bertacini de Moraes, Cláudia Goldenstein‐Schainberg, Henrique A. M. Giardini, Henrique C. Silva, Victor A. O. Martins, Lorena Elizabeth Betancourt Villamarín, Renata Soares, Lucas Peixoto Sales, Carlo Scognamiglio Renner Araújo, Matheus S. R. Silva, Dilson M. N. Filho, Marta Heloísa Lopes, Alberto J. S. Duarte, Esper G. Kallás, Nádia Emi Aikawa, Eloísa Bonfá

    出版 2022
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: